{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:01:50Z","timestamp":1649095310564},"reference-count":27,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2014]]},"DOI":"10.1248\/bpb.b14-00555","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T02:08:48Z","timestamp":1414807728000},"page":"1848-1852","source":"Crossref","is-referenced-by-count":0,"title":["Probing AKR1C30 and AKR1C31 with Site-Directed Mutagenesis: Identifying the Roles of Residues 54 and 56 in the Binding of Substrates and Inhibitors"],"prefix":"10.1248","volume":"37","author":[{"given":"Satoshi","family":"Endo","sequence":"first","affiliation":[{"name":"Laboratory of Biochemistry, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Arai","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ikari","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ossama","family":"El-Kabbani","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Science, Faculty of Engineering, Gifu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kitade","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Science, Faculty of Engineering, Gifu University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hoffmann F, Maser E. Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase\/reductase superfamily. <i>Drug Metab. Rev.<\/i>, <b>39<\/b>, 87\u2013144 (2007).","DOI":"10.1080\/03602530600969440"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Barski OA, Tipparaju SM, Bhatnagar A. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. <i>Drug Metab. Rev.<\/i>, <b>40<\/b>, 553\u2013624 (2008).","DOI":"10.1080\/03602530802431439"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Matsunaga T, Shintani S, Hara A. Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. <i>Drug Metab. Pharmacokinet.<\/i>, <b>21<\/b>, 1\u201318 (2006).","DOI":"10.2133\/dmpk.21.1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Jin Y, Penning TM. Aldo-keto reductases and bioactivation\/detoxication. <i>Annu. Rev. Pharmacol. Toxicol.<\/i>, <b>47<\/b>, 263\u2013292 (2007).","DOI":"10.1146\/annurev.pharmtox.47.120505.105337"},{"key":"5","unstructured":"5) Ishikura S, Nakajima S, Kaneko T, Shintani S, Usami N, Yamamoto I, Carbone V, El-Kabbani O, Hara A. Comparison of stereoselective reduction of 3- and 20-oxosteroids among mouse and primate 20\u03b1-hydroxysteroid dehydrogenases. <i>Enzymology and molecular biology of carbonyl metabolism<\/i> 12 (Weiner H, Plapp B, Lindahl R, Maser E, eds.) Purdue University Press, West Lafayette, pp. 341\u2013351 (2005)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ishikura S, Usami N, Nakajima S, Kameyama A, Shiraishi H, Carbone V, El-Kabbani O, Hara A. Characterization of two isoforms of mouse 3(17)\u03b1-hydroxysteroid dehydrogenases of the aldo-keto reductase family. <i>Biol. Pharm. Bull.<\/i>, <b>27<\/b>, 1939\u20131945 (2004).","DOI":"10.1248\/bpb.27.1939"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ishikura S, Matsumoto K, Sanai M, Horie K, Matsunaga T, Tajima K, El-Kabbani O, Hara A. Molecular cloning of a novel type of rat cytoplasmic 17\u03b2-hydroxysteroid dehydrogenase distinct from the type 5 isozyme. <i>J. Biochem.<\/i>, <b>139<\/b>, 1053\u20131063 (2006).","DOI":"10.1093\/jb\/mvj109"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Matsumoto K, Endo S, Ishikura S, Matsunaga T, Tajima K, El-Kabbani O, Hara A. Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. <i>Biol. Pharm. Bull.<\/i>, <b>29<\/b>, 539\u2013542 (2006).","DOI":"10.1248\/bpb.29.539"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Endo S, Matsunaga T, Horie K, Tajima K, Bunai Y, Carbone V, El-Kabbani O, Hara A. Enzymatic characteristics of an aldo-keto reductase family protein (AKR1C15) and its localization in rat tissues. <i>Arch. Biochem. Biophys.<\/i>, <b>465<\/b>, 136\u2013147 (2007).","DOI":"10.1016\/j.abb.2007.05.008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Endo S, Matsunaga T, Horie K, Tajima K, Bunai Y, Carbone V, El-Kabbani O, Hara A. Enzymatic characteristics of an aldo-keto reductase family protein (AKR1C15) and its localization in rat tissues. <i>Arch. Biochem. Biophys.<\/i>, <b>465<\/b>, 136\u2013147 (2007).","DOI":"10.1016\/j.abb.2007.05.008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Couture JF, Legrand P, Cantin L, Labrie F, Luu-The V, Breton R. Loop relaxation, a mechanism that explains the reduced specificity of rabbit 20\u03b1-hydroxysteroid dehydrogenase, a member of the aldo-keto reductase superfamily. <i>J. Mol. Biol.<\/i>, <b>339<\/b>, 89\u2013102 (2004).","DOI":"10.1016\/j.jmb.2004.03.035"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Endo S, Arai Y, Hara A, Kitade Y, Bunai Y, El-Kabbani O, Matsunaga T. Substrate specificity and inhibitor sensitivity of rabbit 20\u03b1-hydroxysteroid dehydrogenase. <i>Biol. Pharm. Bull.<\/i>, <b>36<\/b>, 1514\u20131518 (2013).","DOI":"10.1248\/bpb.b13-00342"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Endo S, Matsunaga T, Matsumoto A, Arai Y, Ohno S, El-Kabbani O, Tajima K, Bunai Y, Yamano S, Hara A, Kitade Y. Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin D<sub>2<\/sub>, and other endogenous and xenobiotic carbonyl compounds. <i>Biochem. Pharmacol.<\/i>, <b>86<\/b>, 1366\u20131375 (2013).","DOI":"10.1016\/j.bcp.2013.08.024"},{"key":"14","unstructured":"14) Endo S, Matsunaga T, Arai Y, Ikari A, Tajima K, El-Kabbani O, Yamano S, Hara A, Kitade Y. Cloning and characterization of four rabbit aldo-keto reductases featuring broad substrate specificity for xenobiotic and endogenous carbonyl compounds: relationship with multiple forms of drug ketone reductases. <i>Drug Metab. Dispos.<\/i>, <b>42<\/b>, 803\u2013812 (2014)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Penning TM. Molecular determinants of steroid recognition and catalysis in aldo-keto reductases. Lessons from 3\u03b1-hydroxysteroid dehydrogenase. <i>J. Steroid Biochem. Mol. Biol.<\/i>, <b>69<\/b>, 211\u2013225 (1999).","DOI":"10.1016\/S0960-0760(99)00038-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Jin Y, Stayrook SE, Albert RH, Palackal NT, Penning TM, Lewis M. Crystal structure of human type III 3\u03b1-hydroxysteroid dehydrogenase\/bile-acid binding protein complexed with NADP<sup>+<\/sup> and ursodeoxycholate. <i>Biochemistry<\/i>, <b>40<\/b>, 10161\u201310168 (2001).","DOI":"10.1021\/bi010919a"},{"key":"17","unstructured":"17) Couture JF, Legrand P, Cantin L, Luu-The V, Labrie F, Breton R. Human 20\u03b1-hydroxysteroid dehydrogenase: Crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids. <i>J. Mol. Biol.<\/i>, <b>331<\/b>, 593\u2013604 (2003)."},{"key":"18","unstructured":"18) Qiu W, Zhou M, Labrie F, Lin SX. Crystal structures of the multispecific 17\u03b2-hydroxysteroid dehydrogenase type 5: critical androgen regulation in human peripheral tissues. <i>Mol. Endocrinol.<\/i>, <b>18<\/b>, 1798\u20131807 (2004)."},{"key":"19","unstructured":"19) Faucher F, Cantin L, Pereira de J\u00e9sus-Tran K, Lemieux M, Luu-The V, Labrie F, Breton R. Mouse 17\u03b1-hydroxysteroid dehydrogenase (AKR1C21) binds steroids differently from other aldo-keto reductases: Identification and characterization of amino acid residues critical for substrate binding. <i>J. Mol. Biol.<\/i>, <b>369<\/b>, 525\u2013540 (2007)."},{"key":"20","unstructured":"20) Dhagat U, Endo S, Mamiya H, Hara A, El-Kabbani O. Structure of the G225P\/G226P mutant of mouse 3(17)\u03b1-hydroxysteroid dehydrogenase (AKR1C21) ternary complex: implications for the binding of inhibitor and substrate. <i>Acta Crystallogr. D Biol. Crystallogr.<\/i>, <b>65<\/b>, 257\u2013265 (2009)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) El-Kabbani O, Scammells PJ, Gosling J, Dhagat U, Endo S, Matsunaga T, Soda M, Hara A. Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20\u03b1-hydroxysteroid dehydrogenase (AKR1C1). <i>J. Med. Chem.<\/i>, <b>52<\/b>, 3259\u20133264 (2009).","DOI":"10.1021\/jm9001633"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Matsuura K, Deyashiki Y, Sato K, Ishida N, Miwa G, Hara A. Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis. <i>Biochem. J.<\/i>, <b>323<\/b>, 61\u201364 (1997).","DOI":"10.1042\/bj3230061"},{"key":"23","unstructured":"23) Dhagat U, Endo S, Soda M, Hara A, El-Kabbani O. Factorizing the role of a critical leucine residue in the binding of substrate to human 20\u03b1-hydroxysteroid dehydrogenase (AKR1C1): Molecular modeling and kinetic studies of the Leu308Val mutant enzyme. <i>Bioorg. Med. Chem. Lett.<\/i>, <b>20<\/b>, 5274\u20135276 (2010)."},{"key":"24","unstructured":"24) Zhang B, Zhu DW, Hu XJ, Zhou M, Shang P, Lin SX. Human 3\u03b1-hydroxysteroid dehydrogenase type 3 (3\u03b1-HSD3): The V54L mutation restricting the steroid alternative binding and enhancing the 20\u03b1-HSD activity. <i>J. Steroid Biochem. Mol. Biol.<\/i>, <b>141<\/b>, 135\u2013143 (2014)."},{"key":"25","unstructured":"25) Endo S, Matsunaga T, Tajima K, Hara A. Conversion of AKR1C20 into an AKR1C6-type enzyme by site-directed mutagenesis. <i>Enzymology and molecular biology of carbonyl metabolism<\/i> 13 (Weiner H, Maser E, Lindahl R, Plapp B, eds.) Purdue University Press, West Lafayette, pp. 273\u2013280 (2007)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Endo S, Matsunaga T, Fujimoto A, Kumada S, Arai Y, Miura Y, Mikamo H, El-Kabbani O, Yamano S, Iinuma M, Hara A. Characterization of a rabbit morphine 6-dehydrogenase and two NAD<sup>+<\/sup>-dependent 3\u03b1(17\u03b2)-hydroxysteroid dehydrogenases. <i>Arch. Biochem. Biophys.<\/i>, <b>529<\/b>, 131\u2013139 (2013).","DOI":"10.1016\/j.abb.2012.11.013"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RAS, Frey FJ, Langer T, Odermatt A. Comparative enzymology of 11\u03b2-hydroxysteroid dehydrogenase type 1 from six species. <i>J. Mol. Endocrinol.<\/i>, <b>35<\/b>, 89\u2013101 (2005).","DOI":"10.1677\/jme.1.01736"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/37\/11\/37_b14-00555\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T06:22:53Z","timestamp":1615875773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/37\/11\/37_b14-00555\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b14-00555","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}